BOSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the […]

— Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of […]

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) […]

TROY, Mich., Nov. 15, 2024 (GLOBE NEWSWIRE) — Kelly has been named Corporation of the Year by the National Minority […]

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have […]

WESTCHESTER, Ill., Nov. 15, 2024 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), en ledende global leverandør av ingrediensløsninger til bruk […]

WESTCHESTER, Ill., Nov. 15, 2024 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR) een wereldwijd toonaangevende leverancier van ingrediëntenoplossingen voor voedingsmiddelen, […]

WESTCHESTER, Ill., Nov. 15, 2024 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), der er en førende global leverandør af ingrediensløsninger […]